ライフサイエンスコーパス: National Institute of Health

1 States Agency for International Development, National Institutes of Health.

2 L between March 2014 and October 2015 at the National Institutes of Health.

3 nstrument created with the assistance of the National Institutes of Health.

4 Intramural Research Program, NIMH, National Institutes of Health.

5 ters for Disease Control and Prevention, and National Institutes of Health.

6 with safeguards and criteria mandated by the National Institutes of Health.

7 Merck and Co, National Institutes of Health.

8 nstitute of Allergy and Infectious Diseases, National Institutes of Health.

9 National Cancer Institute of the US National Institutes of Health.

10 arch Group, National Cancer Institute of the National Institutes of Health.

11 ealth Research, National Institute on Aging, National Institutes of Health.

12 Humacyte and US National Institutes of Health.

13 the Bill & Melinda Gates Foundation, and the National Institutes of Health.

14 National Heart, Lung, and Blood Institute, National Institutes of Health.

15 nstitute on Alcohol Abuse and Alcoholism, US National Institutes of Health.

16 , National Institute of Mental Health of the National Institutes of Health.

17 ter for Advancing Translational Sciences and National Institutes of Health.

18 ation, Ryoichi Sasakawa Fellowship Fund, and National Institutes of Health.

19 Primary Funding Source: National Institutes of Health.

20 Funding Source: National Institute on Aging, National Institutes of Health.

21 timulation of the subthalamic nucleus at the National Institutes of Health.

22 of Child Health and Human Development and US National Institutes of Health.

23 Complementary and Integrative Health of the National Institutes of Health.

24 r Support (Core), National Cancer Institute, National Institutes of Health.

25 utpatient practices were recruited at the US National Institutes of Health.

26 US Environmental Protection Agency and US National Institutes of Health.

27 ernand Lazard Foundation, Boston University, National Institutes of Health.

28 for Advancing Translational Sciences at the National Institutes of Health.

29 te of Allergy and Infectious Diseases at the National Institutes of Health.

30 itute of Child Health and Human Development, National Institutes of Health.

31 tural Science Foundation of China and the US National Institutes of Health.

32 ellcome Trust, Medical Research Council, and National Institutes of Health.

33 Center for Advancing Translational Sciences, National Institutes of Health.

34 US National Cancer Institute of the National Institutes of Health.

35 ufts/Brown Center for AIDS Research from the National Institutes of Health.

36 non-myeloablative HPC transplantation at the National Institutes of Health.

37 th NPC1 were assessed for eligibility at the National Institutes of Health.

38 lergy and Infectious Diseases (NIAID) at the National Institutes of Health.

39 ation for the Study of Liver Disease and the National Institutes of Health.

40 National Eye Institute, National Institutes of Health.

41 Mayo Clinic, National Institutes of Health.

42 onal Cancer Centre Research Fund, and the US National Institutes of Health (1R01AR062886, 5U01GM09269

43 ses in 517,041 men and women enrolled in the National Institutes of Health-AARP cohort.

44 d lung carcinoma in 492,902 persons from the National Institutes of Health-AARP Diet and Health Study

45 g 190,325 postmenopausal participants in the National Institutes of Health-AARP Diet and Health Study

46 and Catheter Treatment Trial (FACTT) of the National Institutes of Health Acute Respiratory Distress

47 Bill & Melinda Gates Foundation, the National Institutes of Health, Aeras, the European Union

48 ents against a gold standard included in the National Institutes of Health Age-related Eye Disease St

49 The setting was a single-center study at the National Institutes of Health among participants 18 year

50 30, 2016, at the National Cancer Institute, National Institutes of Health (an academic research faci

51 st in improving ventilated patient care, the National Institute of Health and Agency for Healthcare R

52 The UK National Institute of Health and Care Excellence (NICE)

53 ent's Emergency Plan for AIDS Relief and the National Institute of Health and Child Development.

54 n and Asthma Cohort; sponsored by the French National Institute of Health and Medical Research, INSER

55 The National Institutes of Health and American College of Su

56 Following calls from the National Institutes of Health and American College of Su

57 olled at the Clinical Research Center of the National Institutes of Health and associated healthcare

58 US National Institutes of Health and Bill & Melinda Gates F

59 bel (a superb senior virologist who left the National Institutes of Health and came to Scripps), and

60 Primary Funding Source: National Institutes of Health and Doris Duke Charitable

61 National Institutes of Health and German Center for Neur

62 search and development agreement between the National Institutes of Health and Gilead Sciences.

63 Exelixis, National Institutes of Health and National Cancer Instit

64 Previous reports from National Institutes of Health and National Science Found

65 universities and government agencies (e.g., National Institutes of Health and National Science Found

66 National Institutes of Health and President's Emergency

67 The US National Institutes of Health and President's Emergency

68 National Institutes of Health and the Bill & Melinda Gat

69 US National Institutes of Health and the Bill & Melinda Gat

70 National Cancer Institute of the National Institutes of Health and the Mayo Comprehensive

71 National Institutes of Health and the Steve and Deborah

72 he two most active funders in the field: the National Institutes of Health and the US Veterans Admini

73 US National Institutes of Health and US President's Emergen

74 ational Heart, Lung, and Blood Institute (US National Institutes of Health) and the Medtronic Foundat

75 nstitute of Allergy and Infectious Diseases (National Institutes of Health) and the President's Emerg

76 s), Economic and Social Research Council, US National Institutes of Health, and British Heart Foundat

77 dation, Doris Duke Charitable Foundation, US National Institutes of Health, and Fogarty International

78 tes and Digestive and Kidney Diseases of the National Institutes of Health, and National Center for A

79 National Cancer Institute, National Institutes of Health, and the American Lebanese

80 These goals are articulated by the National Institutes of Health as "precision medicine" an

81 dian Cancer Society, Swiss Cancer League, UK National Institutes of Health, Australian National Healt

82 f Health funding (proportion with at least 1 National Institutes of Health award, 10.8% versus 10.4%;

83 hed between 2003 and 2010 and found that the National Institutes of Health awardees who authored thos

84 ucted at the Clinical Research Center of the National Institutes of Health, Bethesda, Maryland, from

85 nstitute of Allergy and Infectious Diseases, National Institutes of Health; Bethesda, MD) and for fun

86 All patients diagnosed with loiasis at the National Institutes of Health between 1976 and 2012 were

87 National Institutes of Health, Bill & Melinda Gates Foun

88 r first report in 2012, 2 Foundation for the National Institutes of Health Biomarkers Consortium Proj

89 Early programs in the National Institutes of Health BRAIN Initiative focus on

90 US National Institutes of Health, Brazilian National Counci

91 provided by the National Cancer Institute of National Institutes of Health (CA127296) with studies in

92 [6.0%] with locally advanced disease) at the National Institutes of Health Clinical Center (Bethesda,

93 ilies and 57 sporadic cases recruited at the National Institutes of Health Clinical Center during 200

94 rs were admitted to an isolation unit at the National Institutes of Health Clinical Center for a mini

95 ences and Intramural Research Program of the National Institutes of Health Clinical Center.

96 Clinical and correlative pilot study at the National Institutes of Health Clinical Center.

97 e disease were defined according to the 2014 National Institutes of Health Consensus Development Conf

98 The 2005 and 2014 National Institutes of Health Consensus Development Proj

99 um women in tuberculosis drug trials, the US National Institutes of Health convened an international

100 onal Institutes of Health criteria, modified National Institutes of Health criteria, Memorial Sloan K

101 5 prognostic scoring systems, including the National Institutes of Health criteria, modified Nationa

102 y end point was cGVHD response based on 2005 National Institutes of Health criteria.

103 US National Heart, Lung, and Blood Institute/National Institutes of Health, Cystic Fibrosis Foundatio

104 t Centers for Disease Control and Prevention/National Institutes of Health diagnostic laboratory was

105 US National Institutes of Health, Elton John AIDS Foundatio

106 National Institutes of Health Fogarty International Cent

107 the Center for Global Health Studies at the National Institutes of Health Fogarty International Cent

108 t-National Institute for Health Research UK, National Institutes of Health, Food and Drug Administrat

109 ital of Philadelphia, Spark Therapeutics, US National Institutes of Health, Foundation Fighting Blind

110 e enrolled in a natural history study at the National Institutes of Health from 2001-2014.

111 ory of Familial Carcinoid Tumor study at the National Institutes of Health from January 2009 to Decem

112 ts in a multicenter, randomized, controlled, National Institutes of Health-funded out-of-hospital car

113 Those enrolled in the National Institutes of Health-funded Sjogren's Internati

114 This National Institutes of Health-funded, multicenter, obser

115 Women were less likely than men to have National Institutes of Health funding (2.0% vs 3.6%; P =

116 ons; P<0.001), were similarly likely to have National Institutes of Health funding (proportion with a

117 ointment to program director, academic rank, National Institutes of Health funding history, and PubMe

118 ion on physician age, years since residency, National Institutes of Health funding, scientific public

119 We searched National Institutes of Health Gene Expression Omnibus an

120 ces of severe grade III to IV acute GVHD and National Institutes of Health grade 2 to 3 chronic GVHD

121 National Institutes of Health, Grand Challenges Canada.

122 ency, cardiology subspecialty, publications, National Institutes of Health grants, and registered cli

123 Methods Experiments were compliant with the National Institutes of Health Guidelines on the Use of L

124 Administration, National Institute on Aging, National Institutes of Health, Harvard Catalyst, and Har

125 National Institutes of Health, Harvard Clinical and Tran

126 General Medical Sciences (NIGMS) at the U.S. National Institutes of Health has an annual budget of mo

127 The US National Institutes of Health has updated their data-sha

128 me Measures in COPD Study), sponsored by the National Institutes of Health, has established a QCT lun

129 m 2 acute heart failure (HF) trials from the National Institutes of Health HF Network, DOSE (Diuretic

130 In June 2016, the National Institutes of Health hosted a workshop on funct

131 of the 47 clusters is present in 88% of the National Institutes of Health Human Microbiome Project (

132 The National Institutes of Health Human Microbiome Project h

133 In response, the National Institutes of Health Immune Tolerance Network a

134 sed fetuses with a diagnosis of CZS from the National Institute of Health in Colombia were sent to th

135 y enrolled adults with T-LGL referred to the National Institutes of Health in Bethesda, MD, USA.

136 study at the Clinical Research Center at the National Institutes of Health included 41 consecutive ad

137 were joined by representatives from several National Institutes of Health institutes and the US Food

138 ild Health and Human Development and partner National Institutes of Health institutes convened a work

139 National Institutes of Health Intramural funds and St Ba

140 ust, Parkinson's UK, Patrick Berthoud Trust, National Institutes of Health, "Investissements d'Avenir

141 stitute of Dental and Craniofacial Research, National Institutes of Health, is designed to accelerate

142 US National Institutes of Health, Janssen Global Public Hea

143 National Institutes of Health National Cancer Institute.

144 National Institutes of Health National Center for Advanc

145 National Institutes of Health, National Cancer Institute

146 US National Cancer Institute, US National Institutes of Health, National Health and Medic

147 National Institutes of Health, National Institute of All

148 cal and Translational Science Award from the National Institutes of Health, National Institute of Art

149 National Institutes of Health, National Institute of Neu

150 National Institutes of Health, National Multiple Scleros

151 Center for Advancing Translational Sciences, National Institutes of Health, National Natural Science

152 so, the American College of Surgeons and the National Institutes of Health-National Institute of Mino

153 The National Institutes of Health/National Heart, Lung, and

154 The National Institutes of Health needs to make radical chan

155 part of the data coordinating effort of the National Institute of Health (NIH) Common Fund's Metabol

156 To review National Institute of Health (NIH) grants targeting skin

157 gency for International Development (USAID), National Institute of Health (NIH), Foundation Center, a

158 Previous reports recommended that the National Institutes of Health (NIH) allocate funding pro

159 as compared with 6% of trials funded by the National Institutes of Health (NIH) and 9% of trials tha

160 The Commons, under active development at the National Institutes of Health (NIH) and elsewhere, as an

161 ch investments made in developing OCT by the National Institutes of Health (NIH) and the National Sci

162 In May 2014, the U.S. National Institutes of Health (NIH) announced that it wi

163 The U.S. National Institutes of Health (NIH) annually invests app

164 In 1961, the National Institutes of Health (NIH) began to circulate b

165 Recognizing this issue, in 2013, the U.S. National Institutes of Health (NIH) Common Fund issued a

166 The National Institutes of Health (NIH) Common Fund supports

167 This article describes efforts at the National Institutes of Health (NIH) from 2013 to 2016 to

168 ed by number of publications, citations, and National Institutes of Health (NIH) funding from PhD sci

169 National Institutes of Health (NIH) grants are becoming

170 Using data on patents linked to U.S. National Institutes of Health (NIH) grants over a 27-yea

171 All patients included were examined at the National Institutes of Health (NIH) in Bethesda, Marylan

172 ut a recent analysis of grants funded by the National Institutes of Health (NIH) in the US found that

173 The National Institutes of Health (NIH) is poised to lift it

174 I remain actively engaged in research at the National Institutes of Health (NIH) notwithstanding 50 m

175 tional, retrospective study conducted by the National Institutes of Health (NIH) of 282 adult and ped

176 National Institutes of Health (NIH) participants underwe

177 This National Institutes of Health (NIH) Pathways to Preventi

178 The National Institutes of Health (NIH) Pathways to Preventi

179 The National Institutes of Health (NIH) Pathways to Preventi

180 In June 2015, the National Institutes of Health (NIH) released a Guide not

181 ether LT at centers that participated in the National Institutes of Health (NIH) Solid Organ Transpla

182 rge part because of the strategy used by the National Institutes of Health (NIH) to invest its budget

183 This study examines funding from the National Institutes of Health (NIH) to US dental institu

184 The National Institutes of Health (NIH) will continue to imp

185 ze oral cavity cancer (OCC) funding from the National Institutes of Health (NIH) with a secondary aim

186 using three Nocardia libraries, the Bruker, National Institutes of Health (NIH), and The Ohio State

187 NPC1 with neurological manifestation at the National Institutes of Health (NIH), Bethesda, MD, USA.

188 National Institutes of Health (NIH), Foundation for the

189 nceton University Health Grand Challenge, US National Institutes of Health (NIH), NIH Fogarty Interna

190 diet and pancreatic cancer incidence in the National Institutes of Health (NIH)-AARP (formerly Ameri

191 The cumulative incidence of National Institutes of Health (NIH)-defined chronic graf

192 esponse, patient-reported outcomes, and 2014 National Institutes of Health (NIH)-response criteria.

193 ular Libraries Roadmap Initiatives of the US National Institutes of Health (NIH).

194 s is a career development (K) award from the National Institutes of Health (NIH).

195 ly available data regarding funding from the National Institutes of Health (NIH).

196 (AIDS Clinical Trials Group [ACTG] A5340 and National Institutes of Health [NIH] 15-I-0140) of the sa

197 US National Cancer Institute, National Institutes of Health Office of Research on Wome

198 Research investments by the National Institutes of Health over this time correlate w

199 ute, Canadian Institutes of Health Research, National Institutes of Health, Pediatric Brain Tumor Fou

200 The recently implemented National Institutes of Health policy requiring that gran

201 Given the recent National Institutes of Health proposal for balanced use

202 Quality assessment was perfomed using the National Institutes of Health quality assessment tool.

203 ncreasing age of investigators at first U.S. National Institutes of Health R01 grant, and exodus of t

204 International AIDS Vaccine Initiative, National Institutes of Health, Ragon Institute, Crucell

205 centers of the Porphyrias Consortium of the National Institutes of Health Rare Diseases Clinical Res

206 As a result of these RCTs, National Institutes of Health recommendations now active

207 Inclusion criteria were adapted from National Institutes of Health recommendations.

208 h as 84% compared with 48% from the original National Institutes of Health registry on idiopathic PAH

209 The new National Institutes of Health requirement to include bot

210 Wellcome Trust, the National Institute of Health Research (NIHR) Biomedical

211 ish Heart Foundation, Dunhill Medical Trust, National Institute of Health Research (NIHR), Medical Re

212 National Health Service (NHS) funding to the National Institute of Health Research Biomedical Researc

213 y capillary hemangiomatosis recruited to the National Institute of Health Research BioResource-Rare D

214 Wellcome Trust, National Institute of Health Research, and Novo Nordisk.

215 National Institute of Health Research, Guy's and St. Tho

216 National Institute of Health Research, Imperial College

217 tion, Bath Unit for Research in Paediatrics, National Institute of Health Research, the Royal United

218 UK National Institute of Health Research.

219 Precision medicine is defined by the National Institute of Health's Precision Medicine Initia

220 to n = 159 clinical cases collected from the National Institutes of Health's LiverTox database to dem

221 The National Institutes of Health's National Institute of En

222 972a was developed in collaboration with the National Institutes of Health's Office of Dietary Supple

223 This Editorial introduces readers to the US National Institutes of Health's Proposed Principles and

224 The Porphyrias Consortium of the National Institutes of Health's Rare Diseases Clinical R

225 PubMed (US National Library of Medicine and National Institutes of Health) search was conducted for

226 This National Institute of Health-sponsored trial will invest

227 The ongoing National Institutes of Health-sponsored Best Endovascula

228 anufacturing facilities participating in the National Institutes of Health-sponsored Clinical Islet T

229 rmed a pilot competing risks analysis of the National Institutes of Health-sponsored PAREPET trial (P

230 ts enrolled in an observational study at the National Institutes of Health starting in 2008 and were

231 day 30, and from 24 h to days 5 and 30; the National Institute of Health Stroke Scale (NIHSS) at bas

232 .4; P < .001) even after adjustment for age, National Institute of Health Stroke Scale (NIHSS) score,

233 Blood glucose level (BGL), National Institute of Health Stroke Scale (NIHSS) score,

234 : (1) longer prehospital duration; (2) lower National Institute of Health stroke scale (NIHSS) score;

235 The score performed slightly better than National Institute of Health Stroke Scale alone regardin

236 cremental predictive value compared with the National Institute of Health Stroke Scale alone.

237 predictors added significantly to the score: National Institute of Health Stroke Scale at admission,

238 hyperintensities were associated with worse National Institute of Health Stroke Scale scores at pres

239 Baseline National Institutes of Health Stroke Scale (median, 15;

240 Patients were 18 to 80 years of age, National Institutes of Health Stroke Scale (NIHSS) </=25

241 ared to the placebo group, the scores of the National Institutes of Health Stroke Scale (NIHSS) and S

242 As a measure of stroke severity, the National Institutes of Health Stroke Scale (NIHSS) is an

243 Although National Institutes of Health Stroke Scale (NIHSS) is an

244 of China, antithrombotic use, high baseline National Institutes of Health Stroke Scale (NIHSS) score

245 During PSR, the National Institutes of Health Stroke Scale (NIHSS) score

246 c stroke in the anterior circulation, higher National Institutes of Health Stroke Scale (NIHSS) score

247 67 years (38% females), and median baseline National Institutes of Health Stroke Scale (NIHSS) score

248 was 68 (+/-13), 62% were female, and median National Institutes of Health Stroke Scale (NIHSS) score

249 nkin Scale (mRS) score at 90 days, change in National Institutes of Health Stroke Scale (NIHSS) score

250 derately severe acute ischaemic stroke and a National Institutes of Health Stroke Scale (NIHSS) score

251 Stroke severity as measured by the National Institutes of Health Stroke Scale (NIHSS; range

252 hose who were not on anticoagulation (median National Institutes of Health Stroke Scale 12, 13, and 9

253 ed 60 years or older with stable disability (National Institutes of Health Stroke Scale [NIHSS] score

254 with a deterioration of at least 4 points on National Institutes of Health Stroke Scale [NIHSS]); and

255 nts had a different 24-hour reduction in the National Institutes of Health Stroke Scale and a favorab

256 known well to arrival time </=4.5 hours and National Institutes of Health Stroke Scale score >/=6.

257 Baseline predictors of early stroke included National Institutes of Health stroke scale score >0, pri

258 -8: 19% decrease in DTN time, 95% CI 6%-31%; National Institutes of Health Stroke Scale score >8: 27%

259 N time, 95% CI 1%-20%), and stroke severity (National Institutes of Health Stroke Scale score 6-8: 19

260 h greater early clinical improvement (median National Institutes of Health Stroke Scale score change:

261 d greater early clinical improvement (median National Institutes of Health Stroke Scale score change:

262 ents with neurologist-diagnosed TIA-S with a National Institutes of Health Stroke Scale score of 0 to

263 ere treated with IV rtPA, 7621 (22.4%) had a National Institutes of Health Stroke Scale score of 5 or

264 At admission, the median National Institutes of Health Stroke Scale score was 10

265 Median National Institutes of Health Stroke Scale score was 16

266 The median National Institutes of Health Stroke Scale score was 21

267 Severity of stroke as determined by the National Institutes of Health Stroke Scale score was not

268 ment for age, sex, baseline stroke severity (National Institutes of Health Stroke Scale score), site

269 nial bleed with >/=4 points worsening on the National Institutes of Health Stroke Scale score).

270 in the drip-and-ship group (median baseline National Institutes of Health Stroke Scale score, 15 vs

271 %) men; mean [SD] age, 72 [13] years; median National Institutes of Health Stroke Scale score, 5; mea

272 The 2 groups were matched for age, baseline National Institutes of Health Stroke Scale score, and gl

273 fter adjusting the analysis for the baseline National Institutes of Health Stroke Scale score, diffus

274 regression model, controlling for admission National Institutes of Health Stroke Scale score, histor

275 farin anticoagulation, high (>/=15) baseline National Institutes of Health Stroke Scale score, larger

276 Calculations were adjusted for age, National Institutes of Health Stroke Scale score, previo

277 ng lesion volume and clinical criteria (age, National Institutes of Health Stroke Scale score, time f

278 by ambulance, after hours, or with a higher National Institutes of Health Stroke Scale score.

279 Age, hypertension, National Institutes of Health Stroke Scale scores, colla

280 Covariates included stroke severity (National Institutes of Health Stroke Scale), functional

281 In multivariable models, higher National Institutes of Health Stroke Score, lower baseli

282 200 adults with CHB who participated in the National Institutes of Health-supported Hepatitis B Rese

283 The National Institutes of Health, the B Frank and Kathleen

284 Program for Distinguished Young Scholars, US National Institutes of Health, the Chinese National 111

285 us Diseases Division of Intramural Research, National Institutes of Health; the Bill & Melinda Gates

286 Scientific Sessions abstracts, and the 2016 National Institutes of Health Tobacco Regulatory Science

287 esenting a brief overview of a newly planned National Institutes of Health trial, TACT2, in which we

288 onal Heart, Lung, and Blood Institute of the National Institutes of Health (U01 HL096715).

289 care Research in Developing Countries and US National Institutes of Health (U54 MD010724, DP2 MD01047

290 Bill & Melinda Gates Foundation, National Institutes of Health, UK Medical Research Counc

291 US National Institutes of Health, UK Medical Research Counc

292 Council, Swedish Physicians against AIDS, US National Institutes of Health, University of Missouri.

293 Prostate Cancer Foundation, National Institutes of Health, US Department of Defense,

294 Center for AIDS Research, National Institutes of Health, US Department of Energy,

295 te of Allergy and Infectious Diseases of the National Institutes of Health, was created in June 2013.

296 nstitute of Allergy and Infectious Diseases, National Institutes of Health, Wellcome Trust, Bill & Me

297 Pasteur in Cambodia, Institut Pasteur Paris, National Institutes of Health, WHO, Agence Nationale de

298 Bill & Melinda Gates Foundation, US National Institutes of Health, WHO, President's Emergenc

299 roup from within academia, industry, and the National Institutes of Health, with expertise in multimo

300 National Heart, Lung and Blood Institute, National Institutes of Health; with drug supply provided